Cardiovascular leadership LACER leads the Spanish market in cardiovascular products, indicating strong demand and an opportunity to expand internationally through partnerships, licensing, or joint development with global pharmaceutical companies.

Manufacturing scale With a sizable workforce and industrial facilities in Catalonia, Lacer has the capacity to pursue contract manufacturing and toll manufacturing opportunities for healthcare and personal care products.

EU expansion potential Headquartered in Barcelona with an international scope, the company is well positioned to pursue expanded distribution, licensing, or joint ventures in the EU and other regions.

Regulatory and quality As a pharmaceutical manufacturer, Lacer could benefit from targeted regulatory affairs, quality management, serialization, and compliance services to support scale and cross border growth.

Digital transformation There is an opportunity to modernize operations with enterprise resource planning, manufacturing execution systems, data analytics, and automation to boost efficiency, traceability, and margins as the business scales.